Antipodes Partners’s American Tower AMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.4M Buy
436,946
+29,789
+7% +$5.36M 1.45% 34
2025
Q4
$71.5M Buy
407,157
+52,573
+15% +$9.57M 1.5% 29
2025
Q3
$68.2M Buy
+354,584
New +$73.9M 1.53% 28

Other funds holding AMT

Antipodes Partners's AMT Position: Q1 2026 in Review

Antipodes Partners increased its American Tower (AMT) stake by 7.3% in Q1 2026, buying an estimated $5.36M and bringing the position to 436,946 shares worth $75.4M. The position accounts for 1.45% of the portfolio, ranked #34.

Antipodes Partners first reported a position in AMT in Q3 2025 and has held it in 3 quarters since. 1,748 funds tracked by Wall St. Rank hold AMT as of Q1 2026.

  • Antipodes Partners held 436,946 shares of American Tower worth $75.4M as of Q1 2026.
  • Antipodes Partners bought 29,789 American Tower shares in Q1 2026, an estimated $5.36M.
  • American Tower made up 1.45% of Antipodes Partners's portfolio in Q1 2026, its #34 holding.
  • Antipodes Partners first reported a position in American Tower in Q3 2025 and has held it in 3 quarters since.
  • 1,748 funds tracked by Wall St. Rank held American Tower as of Q1 2026.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.